Recurrent Mycosis Fungoides Recruiting Phase 1 / 2 Trials for Pralatrexate (DB06813)

Also known as: Mycosis fungoides recurrent

IndicationStatusPhase
DBCOND0080283 (Recurrent Mycosis Fungoides)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03598998Pembrolizumab and Pralatrexate in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomasTreatment